SYSTEMIC APPROACHES TO CHRONICALLY ILL PATIENTS USING INTEGRATIVE MEDICINE
LOCATION – Sydney | Manly Sebel | 17-18 November 2018
Diagnosis and management of chronic fatigue syndrome, vector borne illnesses and chronic inflammatory response syndrome (CIRS)
During the two days of the 2018 Practitioner Seminar content will cover the diagnosis and management of chronic fatigue syndrome, vector borne illnesses and chronic inflammatory response syndrome (CIRS) as well as interactive workshops and small group discussions. The aim is to develop the skills of the integrative medical practitioner in the clinical management of these complex illnesses.
Dr Antony Underwood MB BS (Syd) FRACP Grad Dip Health Law (Syd)
Co-Founder and Director of Research and Education Spectrumceuticals Pty Ltd
Chronic fatigue syndrome, vector borne illnesses
It is estimated that as many as 250,000 Australians are affected by ME/ CFS. Many go undiagnosed for years or are deemed too difficult to manage, numerous of them suffering long-term morbidity. Dr Schloeffel has developed a system of diagnosis and treating these patients with consistent positive outcomes. These innovative diagnostic concepts allow Physicians and Health Care Practitioners to negotiate the complex symptoms these patients experience. Over 4,000 patients have been seen at Dr Schloeffel’s practice over a 20-year period. Time has revealed a substantial number suffering Vector Borne Illness inclusive of Boreliosis and co- infections. Australia in its unique position regarding Tick Borne Illness – the science is in its infancy-showing only preliminary evidence of Borreliosis in its ticks. The current evidence suggests a relapsing fever type of Borreliosis. Co-infections, particularly Rickettsia, Bartonella, Mycoplasma, Ehrlichia, Anaplasmosis, Q-fever and viruses are well documented. Babesia has been found in some patients without any history of foreign travel lending itself to the understanding that we have vectors carrying this disease. Patients presenting with CFS or VBI are particularly challenging. The aim of this forum is to guide you, the practitioner, through a comprehensive understanding from diagnosis to recovery for these often “Heartsink” patients.
Chronic inflammatory response syndrome (CIRS)
It was in the 1990s when Dr Shoemaker of Maryland, USA linked an illness to a toxin produced by a fish-killing dinoflagellate known as Pfiesteria. Since then, Dr Shoemaker and others have linked the same kind of illness to toxins from mould and termed this illness CHRONIC INFLAMMATORY RESPONSE SYNDROME (CIRS). CIRS occurs when genetically susceptible people are exposed to certain biotoxins – species of Stachybotris, Aspergillus, Penicillium, Chaetomium and Wallemia and possible links to associated tick-borne microbes.
In the late 2000s a nasal spray of vasoactive intestinal polypeptide (VIP) seemed to be a major breakthrough in lowering cytokine levels, particularly C4a, MMP-9 and TGF-beta-1.
The research has continued to the stage where we have around 20 peer reviewed papers, on what has now being called chronic inflammatory response syndrome (CIRS). And although the research is ongoing, the question needs to be asked with all chronically ill patients with multisystem disorders, “is your patient suffering with a chronic version of sepsis syndrome?
OUR SEMINAR SPEAKERS
SEMINAR PROGRAM OVERVIEW
Early Bird 20% discount applies to 30th June then the cost is $688 inc. GST
Day 1 Saturday 17th November
Day 2 Sunday 18th November
An application by Spectrumceuticals Medical Advisory Committee for RACGP Points has been lodged, the outcome of the approval decision will be posted on this website when information becomes available for those general practitioners interested.
Strictly limited capacity of 50 practitioner delegates.
Registration is for All Sessions only, single day or single sessions are not available.
Accommodation is not included. Morning tea, lunch and afternoon tea are included.
Seminar dinner is not included this price and requires separate registration.